In a double-blind trial involving 69 patients, the effect of O-(β-hydroxyethyl) rutoside (HR)* in the treatment of varicosis of pregnancy has been investigated. The number of patients subjectively improving in the active drug group was significantly greater than in the placebo group; patients receiving HR also showed a small but significant decrease in leg circumference. Throughout the eight-week period of the trial, there were only minimal side-effects and healthy babies were delivered with good Apgar-scores.
Get full access to this article
View all access options for this article.
References
1.
de AlvarezR R (1963) Discussion of paper by McCausland—Venous disteasibility during the menstrual cycle. American Journal of Obstetrics and Gynaecology86, 644
2.
ArtursonG (1972) Effects of O-(β-hydroxyethyl)-rutoside (HR) on the increased microvascular permeability in experimental skin burns. Acta Chirurgica Scandinavia138, 111
3.
ten CateJ Wvan HaeringenN JGerritsenJGlasiusE (1973) Biological activity of a semi-synthetic flavonoid, O-(β-hydroxyethyl) rutoside: Light-scattering and metabolic studies of human red cells and platelets. Clinical Chemistry19, 31
4.
ChantA DB (1973) The effect of Paroven (HR) on the clearance of sodium-24 from the subcutaneous tissues of the foot in patients with varicose veins. VASA, Journal for Vascular Diseases2, 288
5.
GerlachE (1968) The influence of Venoruton injectabile on the varicose syndrome with special reference to capillary resistance and capillary permeability. Medizinische Monatsschrift22, 414
6.
van HaeringenN JGlasiusEten CateJ WGerritsenJvan GeetJ (1973) Effect of O(β-hydroxyethyl)-rutoside on red cell and platelet functions in man. Bibliotheca Anatomica12, 459 (7th European Conference on Microcirculation, Aberdeen, 1972)
7.
KappertA (1969) Klinische Untersuchungen über die Schwangerschaftsvarikosc. Zentralblatt für Phlebologie8, 81
8.
LudwigH (1964) Schwangerschaftsvarikosis. Zentralblatt für Phlebologie3, 22
9.
LundFFagrellBKunickiJGlenneP-O (1970) The effect of O-(β-hydroxyethyl) rutoside in post-ischaemic and stasis oedema of the rat tail. Third International Congress of Phlebology, Amsterdam, 1968. Stenvert & Son, Apeldoorn, Holland
10.
MeCauslandA MHymanChWinsorTTrotterA DJr (1961) Venous distensibility during pregnancy. American Journal of Obstetrics and Gynaecology81, 472
11.
McEwanA JMcArdleC S (1971) Effect of hydroxyethylrutosidcs on blood oxygen levels and venous insufficiency symptoms in varicose veins. British Medical Journal2, 138
12.
PatersonR AHeathHCranfieldT (1974) The effect of O-(β-hydroxycthyl) rutoside on platelet intermediary metabolism in normal and streptozotocin diabetic rats. Biochemical Pharmacology23, 1591
13.
PřerovskýIRoztočilKHlavováAKoleilatZRázgováLOlivaI (1972) The effect of hydroxyethylrutosides after acute and chronic oral administration in patients with venous diseases. Angiolagica9, 408
14.
RázgováLRoztočilKHálováJFischerA (1971) The effect of O-(β-hydroxyeihyl)-rutosides (HR) on peripheral blood vessels of the lower extremities in idiopathic oedema. European Journal of Clinical Pharmacology3, 247
15.
RoseS S (1970) A report on the use of an hydroxyethylrutosidc in symptoms due to venous back pressure and allied conditions in the lower limbs. The British Journal of Clinical Practice24, 161
16.
RoztočilKFisherANovákPRázgováL (1971) The effect of O-(β-hydroxycthyl)-rutosides (HR) on the peripheral circulation in patients with chronic venous insufficiency. European Journal of Clinical Pharmacology3, 243
17.
SamartzisSHauserG A (1971) Incidence and treatment of pain in legs and veins during pregnancy. Therapeutische Umschau28, 485
18.
TschoppM.PomettaDBabelJ (1970) Diabetic retinopathy: Study of the action of O-(β-hydroxyethyl)-rutosidcs (HR) by retinal fluorcsceinography. Diabetologia6, 475
